William Brody - International Business Independent Director
IBM Stock | USD 183.10 0.65 0.35% |
Director
Dr. William R. Brody M.D. Ph.D. is no longer Independent Director of International Business Machines Corporationrationration. effective April 2016. He is president of the Salk Institute for Biological Studies a nonprofit scientific research institution. He is a member of IBMs Directors and Corporationrationrate Governance Committee. From 1987 to 1994 Dr. Brody was the Martin Donner Professor and director of the Department of Radiology professor of electrical and computer engineering and professor of biomedical engineering at The Johns Hopkins University and radiologistinchief of The Johns Hopkins Hospital. He was the provost of the Academic Health Center at the University of Minnesota from 1994 until 1996. Dr. Brody was president of The Johns Hopkins University from 1996 to 2009. He is a director of all T. Rowe Price fund companies and BioMed Realty Trust. Dr. Brody is a trustee of the W.M. Keck Foundation. Additionally during the past five years he served as a director of Novartis AG. Dr. Brody became an IBM director in 2007. since 2007.
Age | 71 |
Tenure | 17 years |
Address | One New Orchard Road, Armonk, NY, United States, 10504 |
Phone | 914 499 1900 |
Web | https://www.ibm.com |
International Business Management Efficiency
The company has Return on Asset of 0.0471 % which means that on every $100 spent on assets, it made $0.0471 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3367 %, implying that it generated $0.3367 on every 100 dollars invested. International Business' management efficiency ratios could be used to measure how well International Business manages its routine affairs as well as how well it operates its assets and liabilities. At this time, International Business' Return On Capital Employed is very stable compared to the past year. As of the 18th of April 2024, Return On Assets is likely to grow to 0.06, while Return On Tangible Assets are likely to drop 0.07. At this time, International Business' Asset Turnover is very stable compared to the past year.Similar Executives
Showing other executives | DIRECTOR Age | ||
Don Cornwell | Pfizer Inc | 69 | |
Mark Harrison | Home Federal Bancorp | 58 | |
Scott Davis | Johnson Johnson | 66 | |
Ian Davis | Johnson Johnson | 70 | |
Mary Coleman | Johnson Johnson | 70 | |
Woodus Humphrey | Home Federal Bancorp | 77 | |
Dennis Ausiello | Pfizer Inc | 71 | |
Jennifer Doudna | Johnson Johnson | 57 | |
James Quincey | Pfizer Inc | 56 | |
Frances Fergusson | Pfizer Inc | 71 | |
Ronald Williams | Johnson Johnson | 71 | |
Clyde Patterson | Home Federal Bancorp | 74 | |
Yu Sun | China Merchants Bank | 55 | |
Susan Hockfield | Pfizer Inc | 70 | |
Lan Yan | China Merchants Bank | 55 | |
Yueying Sun | China Merchants Bank | 60 | |
Shixiong Wang | China Merchants Bank | 65 | |
Anne Mulcahy | Johnson Johnson | 68 | |
Wyllie Cornwell | Pfizer Inc | 71 | |
Gangfeng Fu | China Merchants Bank | 51 | |
Min Su | China Merchants Bank | 50 |
Management Performance
Return On Equity | 0.34 | |||
Return On Asset | 0.0471 |
International Business Leadership Team
Elected by the shareholders, the International Business' board of directors comprises two types of representatives: International Business inside directors who are chosen from within the company, and outside directors, selected externally and held independent of International. The board's role is to monitor International Business' management team and ensure that shareholders' interests are well served. International Business' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, International Business' outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Rosamilia, Senior Vice President - Systems and Technology Group and IBM Integrated Supply Chain | ||
Andrew Liveris, Independent Director | ||
Nickle LaMoreaux, Chief Human Resource Officer, Senior Vice President | ||
Erich Clementi, Senior Vice President - Global Technology Services | ||
James Kavanaugh, Senior Vice President, Chief Financial Officer, Finance and operation | ||
Kenneth Chenault, Director | ||
Kathryn Guarini, Chief Officer | ||
Alexander Stern, MA, Strategy | ||
Mark Fields, Director | ||
Nicola Hodson, Chief Ireland | ||
Joanne Wright, Senior Operations | ||
Hutham Olayan, Director | ||
Kirill Korniliev, VP Europe | ||
Michelle Howard, Independent Director | ||
David Farr, Independent Director | ||
Alfred Zollar, Independent Director | ||
Martin Schroeter, Senior Vice President - Global Markets, | ||
Martha Pollack, Independent Director | ||
Ana Assis, Chairman Africa | ||
Thomas Buberl, Independent Director | ||
Walter McNerney, Independent Director | ||
Gary Cohn, Executive Chairman | ||
Frederick Waddell, Independent Director | ||
Arvind Krishna, Senior Vice President - Cloud and Cognitive Software | ||
Sidney Taurel, Independent Director | ||
William Brody, Independent Director | ||
John Kelly, Senior Vice President Director - Research | ||
James McNerney, Independent Director | ||
James Whitehurst, President | ||
Sebastian Krause, Senior Officer | ||
Bridget Kralingen, Senior Vice President - Global Business Services | ||
Dario Gil, Senior Research | ||
Jonathan Adashek, Senior Officer | ||
Ric Lewis, Senior Infrastructure | ||
Kenneth Keverian, Senior Vice President - Corporate Strategy | ||
Bernard Meyerson, Chief Emeritus | ||
Alex Gorsky, Independent Director | ||
Kareem Yusuf, Senior Software | ||
Michael Rhodin, Senior Vice President - IBM Watson Group | ||
Diane Gherson, Chief Human Resource Officer, Senior Vice President | ||
Robert LeBlanc, Senior Vice President - Software and Cloud Solutions Group | ||
Alain Belda, Independent Director | ||
Martin Jetter, Sr. VP of IBM Global Technology Services | ||
Shirley Jackson, Independent Director | ||
Colleen Arnold, Senior Vice President - Sales and Distribution | ||
Bruno Leo, Senior Vice President - Sales and Distribution | ||
Frederick McNabb, Independent Director | ||
James Owens, Independent Director | ||
Robert Bene, Vice President Controller | ||
Jon Iwata, Senior Vice President - Marketing and Communications | ||
Tatyana Sorokina, Head Branch | ||
Patricia Murphy, Vice President - Investor Relations | ||
Roger Premo, Gen Strategy | ||
Virginia Rometty, Chairman of the Board, President, Chief Executive Officer | ||
Robert Picciano, Senior Vice President - Information and Analytics Group | ||
Peter Voser, Independent Director | ||
Dinesh Nirmal, Senior Software | ||
Joan Spero, Independent Director | ||
Stanley Sutula, Vice President Controller | ||
Robert Thomas, Senior Officer | ||
Kelly Chambliss, Americas Consulting | ||
Nataraj Nagaratnam, Chief Security | ||
Joseph Swedish, Independent Director | ||
Michelle Browdy, Senior Vice President - Legal and Regulatory Affairs and General Counsel | ||
Michael Eskew, Lead Independent Director | ||
Steven Mills, Executive VP of Software and Systems |
International Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is International Business a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.34 | |||
Return On Asset | 0.0471 | |||
Profit Margin | 0.12 % | |||
Operating Margin | 0.23 % | |||
Current Valuation | 215.03 B | |||
Shares Outstanding | 916.75 M | |||
Shares Owned By Insiders | 0.11 % | |||
Shares Owned By Institutions | 60.66 % | |||
Number Of Shares Shorted | 23.29 M | |||
Price To Earning | 24.45 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in International Business Machines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the International Business information on this page should be used as a complementary analysis to other International Business' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for International Stock analysis
When running International Business' price analysis, check to measure International Business' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy International Business is operating at the current time. Most of International Business' value examination focuses on studying past and present price action to predict the probability of International Business' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move International Business' price. Additionally, you may evaluate how the addition of International Business to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is International Business' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of International Business. If investors know International will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about International Business listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.2 | Dividend Share 6.63 | Earnings Share 8.16 | Revenue Per Share 67.888 | Quarterly Revenue Growth 0.041 |
The market value of International Business is measured differently than its book value, which is the value of International that is recorded on the company's balance sheet. Investors also form their own opinion of International Business' value that differs from its market value or its book value, called intrinsic value, which is International Business' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because International Business' market value can be influenced by many factors that don't directly affect International Business' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between International Business' value and its price as these two are different measures arrived at by different means. Investors typically determine if International Business is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, International Business' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.